Carlsmed (CARL) vs Avita Medical (RCEL)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Avita Medical (RCEL) has outperformed Carlsmed (CARL) over the past year, gaining 138.6% versus a gain of 5.8%. Avita Medical is the larger company by market cap ($403.6 million vs $392.6 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CARL | RCEL |
|---|---|---|
| Share price | $14.38 | $13.05 |
| Market cap | $392.61M | $403.60M |
| 1-day change | -1.78% | +0.46% |
| YTD return | +16.44% | +278.26% |
| 1-year return | +5.81% | +138.57% |
| 5-year return | — | -24.87% |
| EPS (TTM) | $-1.06 | $-1.43 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $17.23 | $13.50 |
| 52-week low | $8.50 | $3.22 |
| Distance from 52-week high | -16.54% | -3.33% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +33.52% | -7.82% |
| Average volume | 127.70K | 444.55K |
| Shares outstanding | 27.30M | 30.93M |
| Employees | 127 | 226 |
| Sector | Healthcare | Healthcare |
| Industry | Health Information Services | Medical Devices |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- RCEL has outperformed CARL by 132.8 percentage points over the past year.
About Carlsmed
CARL stock →Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures.
Healthcare · Health Information Services · 127 employees
About Avita Medical
RCEL stock →AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds and full-thickness skin defects, as well as for repigmentation of stable depigmented vitiligo lesions.
Healthcare · Medical Devices · 226 employees
CARL vs RCEL FAQ
Which is bigger, Carlsmed or Avita Medical?
Avita Medical (RCEL) is larger, with a market capitalization of $403.60M compared with $392.61M for Carlsmed (CARL).
Which stock has performed better over the past year, CARL or RCEL?
RCEL returned +138.57% over the past 12 months, compared with +5.81% for CARL (price return, excluding dividends). Past performance does not predict future results.
Are Carlsmed and Avita Medical in the same industry?
Both are in the Healthcare sector, but in different industries: Health Information Services for Carlsmed and Medical Devices for Avita Medical.